CTOs on the Move

Mr Grab Bar Inc

www.mrgrabbar.com

 
Mr Grab Bar Inc is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mrgrabbar.com
  • 5100 Tamiami Trl N Ste 143
    Naples, FL USA 34103
  • Phone: 239.514.4722

Executives

Name Title Contact Details

Similar Companies

global healthcare associates inc

global healthcare associates inc is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Expressable

Expressable is an online speech therapy platform that offers 1 on 1 virtual sessions with experienced speech therapists, personalized curriculum, and weekly homework assignments to help integrate practice throughout daily life.

Confluent Health

We are a Louisville-based healthcare holdings company with physical therapy partners in over 530+ clinics across 29 states. Confluent Health transforms physical health by effectively meeting the needs of the communities we serve: patients, employers, payors, students, and providers. Primarily focusing on physical and occupational therapy, which provides long-lasting outcomes without surgery, medication, or diagnostic imaging, Confluent Health companies aid in reducing healthcare expenditures and increasing overall population health. Our companies focus on the following services: * Outpatient Physical and Occupational Therapy * Workplace Injury Prevention Through Early Intervention and Employee Screening * Advanced and Entry-Level Education for Physical Therapists and Occupational Therapists No matter what clinic you`re at or where you`re being seen, we have one goal - to get you back to your life, faster.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

KeyMedical Software

KeyMedical Software is a Lebanon, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.